Skip Navigation
Johns Hopkins Medicine International
 
 
 
In This Section      
Print This Page

Johns Hopkins Singapore

Singapore International Medical Centre

Singapore

Overview

Johns Hopkins Singapore, which opened in 2000 and has been located in Tan Tock Seng Hospital since 2005, is Johns Hopkins’ only jointly owned and managed facility outside the United States.

It offers patients a geographical alternative for Johns Hopkins oncology care—a state-of-the-art service with 30 inpatient beds, including a high-end presidential suite for dignitaries and an outpatient unit for chemotherapy—in a modern Asian setting that’s culturally diverse and sensitive to the needs of both Singaporeans and international patients.

The 1,200-bed Tan Tock Seng Hospital, established in 1844, is the second-largest acute care general hospital in Singapore, with specialty centers in rehabilitation medicine and communicable diseases. The hospital is a member of the National Healthcare Group and provides high-quality holistic health care services to the people of Singapore.

Joint Commission International Accreditation

Joint Commission International (2004, 2007, 2010, 2013)

August 2004 (first private hospital in Singapore)

About Our Agreement

In 1998, the Singapore government signed an agreement with Johns Hopkins Medicine and set out to develop the country’s first private medical facility that combines clinical research and teaching with patient care services. Under this agreement, Johns Hopkins Singapore International Medical Centre opened in 2000.

Some highlights:

  • Treatment and clinical research programs focus on solid tumors such as breast, colon, lung and prostate, plus liver, gastric and nasopharyngeal cancers-the most common among Asians
  • Opened a gynecologic surgery program in 2004
  • Oncology rotations, lectures, observerships, visiting professorship and symposia to facilitate knowledge transfer between Baltimore and Singapore
  • Works in collaboration with researchers from Johns Hopkins in Baltimore, National University of Singapore and National Cancer Centre, Singapore
  • Supports health awareness activities in the local community
  • Clinical trials and research focus:
    • Conduct studies into genetic basis of diseases among Asians to tailor therapies for Asian population
    • Develop novel therapies for diseases prevalent in this region
    • Active studies in the areas of breast, lung, nasopharyngeal, GI, renal and gastric cancers

Points of Pride

  • One of the leading oncology centers in Singapore
  • First private hospital in Singapore to receive Joint Commission International accreditation
  • Each year, the centre sees more than 1,400 new cancer patients from the Asia-Pacific and Middle East regions
  • Clinical trials and research focus:
    • Genetic basis of Asian diseases to tailor therapies for Asian population
    • Develop novel therapies for diseases prevalent in this region
    • Active studies in the areas of breast, lung, nasopharyngeal, renal and gastric cancers
    • 65 clinical trials have been completed to date, with 13 active studies under way

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer